Central Pacific Bank - Trust Division’s Merit Medical Systems MMSI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$214K Sell
2,487
-620
-20% -$51.9K 0.02% 451
2026
Q2
$215K Buy
3,107
+380
+14% +$25.1K 0.02% 459
2026
Q1
$188K Buy
2,727
+490
+22% +$38.3K 0.02% 467
2025
Q4
$197K Sell
2,237
-63
-3% -$5.36K 0.02% 437
2025
Q3
$191K Buy
2,300
+720
+46% +$62.7K 0.02% 459
2025
Q2
$148K Sell
1,580
-200
-11% -$18.9K 0.02% 500
2025
Q1
$188K Hold
1,780
– – 0.03% 450
2024
Q4
$172K Buy
1,780
+100
+6% +$9.97K 0.02% 493
2024
Q3
$166K Sell
1,680
-570
-25% -$52.2K 0.02% 486
2024
Q2
$193K Buy
2,250
+480
+27% +$37.7K 0.02% 544
2024
Q1
$133K Buy
+1,770
New +$137K 0.02% 623

Other funds holding MMSI

Central Pacific Bank - Trust Division's MMSI Position: Q3 2026 in Review

Central Pacific Bank - Trust Division reduced its Merit Medical Systems (MMSI) stake by 20% in Q3 2026, selling an estimated $51.9K and leaving 2,487 shares worth $214K. The position accounts for 0.02% of the portfolio, ranked #451.

Central Pacific Bank - Trust Division first reported a position in MMSI in Q1 2024 and has held it in 11 quarters since. The position peaked at $215K in Q2 2026. 15 funds tracked by Wall St. Rank hold MMSI as of Q3 2026.

  • Central Pacific Bank - Trust Division held 2,487 shares of Merit Medical Systems worth $214K as of Q3 2026.
  • Central Pacific Bank - Trust Division sold 620 Merit Medical Systems shares in Q3 2026, an estimated $51.9K.
  • Merit Medical Systems made up 0.02% of Central Pacific Bank - Trust Division's portfolio in Q3 2026, its #451 holding.
  • Central Pacific Bank - Trust Division first reported a position in Merit Medical Systems in Q1 2024 and has held it in 11 quarters since.
  • Central Pacific Bank - Trust Division's Merit Medical Systems position peaked at $215K in Q2 2026.
  • 15 funds tracked by Wall St. Rank held Merit Medical Systems as of Q3 2026.

Based on Central Pacific Bank - Trust Division's 13F filing for Q3 2026, filed 6 Oct 2026.